Research Into the Effect of Proton Pump Inhibitors on Lungs and Leukocytes

ÖZATİK O., ÖZATİK F. Y., TEKŞEN Y., Dag L., KARADENİZ SAYGILI S., KOÇAK A.

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.32, no.12, pp.1003-1011, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 12
  • Publication Date: 2021
  • Doi Number: 10.5152/tjg.2021.20550
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1003-1011
  • Keywords: ARDS, H2 receptors blockers, immune deficiency, lung, proton pump inhibitors, PANTOPRAZOLE
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background: Proton pump inhibitors (PPI) are the most commonly used medication in the world. They are prescribed as an effective treatment choice for gastrointestinal system diseases linked to hyperacidity, especially. Additionally, non-indication and unnecessary use are very common. Many publications in recent times have reported significant side effects. However, there are insufficient studies about the mechanism for these side effects.